National Advisory Committee on Immunization (NACI) is now recommending two doses of the Pfizer-BioNTech COVID-19 vaccine be used in those aged 12 to 18 years old.The updated advisory comes weeks after Health Canada approved the vaccine for use in adolescents aged 12 to 15.
Pfizer COVID-19 vaccine approved for Canadians 12 and over, Health Canada says When the vaccine was initially green-lit for use in December 2020, NACI recommended it be used in those 16 and older.NACI said the Pfizer-BioNTech vaccine is “safe and effective for adolescents.”“Clinical trial evidence showed 100 per cent efficacy in adolescents 12 to 15 years of age against confirmed COVID-19 illness,” the statement read.In a statement Tuesday, NACI chair Dr.